Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study reveals flaws in long-read DNA technology
The researchers suggest that data produced by long-read technologies should be interpreted with caution.
Findings suggest that correcting software is unreliable

Researchers at the University of Edinburgh’s Roslin Institute have warned of flawed data from long-read DNA readings.

New technologies that can read long strings of DNA are up to 99.8 per cent accurate.  But in a genome of more than three billion letters, this could equate to millions of errors.

Scientists say that such mistakes could falsely suggest that a person has a genetic make-up that heightens their risk of a certain disease. Data produced by these technologies should, therefore, be interpreted with caution, the team suggests, as it could create problems for analysing genetic information from people and animals.

“Long-read technologies are incredibly powerful but it is clear that we can’t rely on software tools to correct errors in the data – some hands-on expertise may still be required,” explained Professor Mic Watson of the Roslin Institute. “This is important as we increasingly use genomic technologies to understand the world around us.”

Writing in the Nature Biotechnology, the researchers describe an analysis of three recent studies reporting human genome sequences from long-read methods. They found that the data contained thousands of mistakes, even after using corrective software.

The team writes that such errors could have major implications if the methods are used in clinical studies to diagnose patients.

“Long-read technologies are incredibly powerful but it is clear that we can’t rely on software tools to correct errors in the data – some hands-on expertise may still be required,” said Professor Mick Watson, of the University of Edinburgh’s Roslin Institute.

“This is important as we increasingly use genomic technologies to understand the world around us.”

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.